(AUST:AVH.AX),(NASDAQ:RCEL), VALENCIA, Calif., May 08, 2025 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights and Recent Developments Commercial revenue of $18.5 million, an increase of approximately […]

(NASDAQ:TXRH), LOUISVILLE, KY., May 08, 2025 (GLOBE NEWSWIRE) — Texas Roadhouse, Inc. (NasdaqGS: TXRH), today announced financial results for the 13 weeks ended April 1, 2025. Financial Results Financial results for the 13 weeks ended April 1, 2025 and March 26, 2024 were as follows: 13 Weeks Ended ($000's, except per share amounts) April 1,

(NasdaqGM:NNOX), PETACH TIKVA, Israel, May 08, 2025 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (“Nanox” or the “Company”, Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2025, before market open on Thursday, May 22, 2025. Erez Meltzer, Chief Executive Officer and

Texas Roadhouse, Inc. Announces First Quarter 2025 Results Declares Quarterly Dividend of $0.68 per Share GlobeNewswire May 08, 2025 LOUISVILLE, KY., May 08, 2025 (GLOBE NEWSWIRE) — Texas Roadhouse, Inc. (NasdaqGS: TXRH), today announced financial results for the 13 weeks ended April 1, 2025. Financial Results Financial results for the 13 weeks ended April 1,

PDF Solutions(R) Announces First Quarter 2025 Financial Results GlobeNewswire May 08, 2025 SANTA CLARA, Calif., May 08, 2025 (GLOBE NEWSWIRE) — PDF Solutions, Inc. (Nasdaq: PDFS), a leading provider of comprehensive data solutions for the semiconductor and electronics ecosystem, today announced financial results for its first quarter ended March 31, 2025. Financial Highlights of First

AVITA Medical Reports First Quarter 2025 Financial Results GlobeNewswire May 08, 2025 VALENCIA, Calif., May 08, 2025 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights and

Nanox to Report First Quarter 2025 Financial Results on May 22, 2025 GlobeNewswire May 08, 2025 PETACH TIKVA, Israel, May 08, 2025 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (“Nanox” or the “Company”, Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31,

(NasdaqGM:IOVA), 1Q25 Total Product Revenue of $49.3M FY25 Total Product Revenue Guidance Revised to $250M-$300M FY25 Operating Expenses Reduced and 2H26 Cash Runway Guidance Maintained 2025 Regulatory Approvals for Amtagvi(R) Expected in the UK, EU, and Canada On Track to Report Updated Clinical Data for Registrational Trialin Previously Treated Advanced NSCLC in 2H25 SAN CARLOS,

(NasdaqGM:CRVS), Soquelitinib data from cohorts 1-3 of atopic dermatitis Phase 1 clinical trial demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Phase 3 registrational clinical trial of soquelitinib in peripheral T cell lymphoma (PTCL) enrolling with multiple clinical sites open Early exercise of common stock

(NASDAQ:MTSR), NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) — Metsera, Inc. (Nasdaq: MTSR) (“Metsera” or the “Company”), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced that Whit Bernard, its Chief Executive Officer, will present at the Bank of America 2025 Global Healthcare Conference on Wednesday, May